Gambero A et al. |
Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. |
2004 |
Toxicon |
pmid:15450921
|
Shiroma N et al. |
Haemodynamic and haematologic effects of Acanthaster planci venom in dogs. |
1994 |
Toxicon |
pmid:7846692
|
Havt A et al. |
The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. |
2001 |
Toxicon |
pmid:11600146
|
Castro-Faria-Neto HC et al. |
Pro-inflammatory activity of enterolobin: a haemolytic protein purified from seeds of the Brazilian tree Enterolobium contortisiliquum. |
1991 |
Toxicon |
pmid:1796477
|
Yara A et al. |
Cardiovascular effects of Acanthaster planci venom in the rat: possible involvement of PAF in its hypotensive effect. |
1992 |
Toxicon |
pmid:1440631
|
Freire-Maia L and de Matos IM |
Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. |
1993 |
Toxicon |
pmid:8266352
|
Tai H et al. |
TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. |
2004 |
Toxicon |
pmid:15501291
|
Melo RC et al. |
Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. |
2005 |
Traffic |
pmid:16138901
|
Guerrant RL et al. |
Diarrhea, demography and cell signaling: lessons from microbial toxins. |
1997 |
Trans. Am. Clin. Climatol. Assoc. |
pmid:9108674
|
Shukla SD et al. |
Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity. |
1989 Jul-Aug |
Transfusion |
pmid:2546298
|
Hirt SW et al. |
Antagonisation of platelet activating factor--a new therapeutic concept for improvement of organ quality in lung preservation. |
1992 |
Transpl. Int. |
pmid:14621825
|
Torras J et al. |
Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model. |
1993 |
Transpl. Int. |
pmid:8347271
|
Räisänen A et al. |
Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo. |
1993 |
Transpl. Int. |
pmid:8216700
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Fukunaga K et al. |
Successful liver transplantation from non-heart-beating donors by blockade of endothelin and PAE. |
1998 |
Transplant. Proc. |
pmid:9838664
|
Lloberas N et al. |
The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. |
2002 |
Transplant. Proc. |
pmid:11959179
|
Castellvi J et al. |
Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. |
2002 |
Transplant. Proc. |
pmid:11959181
|
Mahmoud FF et al. |
In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. |
2002 |
Transplant. Proc. |
pmid:12431672
|
Da Costa M et al. |
Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170. |
1990 |
Transplant. Proc. |
pmid:2389490
|
Minor T et al. |
Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft. |
1995 |
Transplant. Proc. |
pmid:7879086
|